Navigation Links
Cough Up More for the Health of Afghan Women, UNFPA Urges

New York – A country notorious for war and strife, Afghanistan, is also infamous with one of the highest maternal mortality rates in the world. //Afghanistan has attracted the attention of the United Nations Population Fund (UNFPA), which has pressed for adequate funds necessary to improve the health of women and children.

The UNFPA is determined to improve the lot of women to include empowerment, maternal health and prevention of AIDS/HIV. The chief of UNFPA is of the opinion that the contribution of women to families and to the community as a whole translates as progress of the nation. Obviously when women are wronged, it shows in the health of the nation; Afghanistan bears testimony to the ills meted out to women.

Therefore, measures to empower and uplift women will benefit Afghanistan as a nation greatly. Putting an end to violence against women, by allowing the men to participate in such endeavors, will bring reprieve to the many who suffer violence silently. The UNFPA key agenda will be offer crucial services in healthcare to women that would encompass the gamut of family planning, proper medical assistance at birth and the right to emergency obstetric care. /L
'"/>




Page: 1

Related medicine news :

1. Cough Syrup Ingredient Linked to Stroke
2. Women Worse Affected By Chronic Cough
3. A Drug That Might Relieve Chronic Cough
4. Studying The Effectiveness Of Cough Syrups
5. Foods Rich In Flavonoids Effective In Prevention Of Cough
6. Cough medication to cure fibromyalgia
7. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
8. Rising Rates of Whooping Cough in Idaho
9. Cough Syrups No More Effective Than Sugar Water
10. Bariatric Surgery: Medicare, Will Now Cough Up For ‘Throwing Weight
11. Zimbabweans Will Need To Cough Up More on Health Costs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cough More for the Health Afghan Women UNFPA Urges

(Date:8/28/2014)... 28, 2014 Home Care Assistance ... for seniors, is proud to welcome Carrie Rose as ... Home Care Assistance, Carrie worked as a caregiver in ... Certified Nursing Assistant in skilled nursing facilities for several ... a trainer with the State of Arizona in the ...
(Date:8/28/2014)... have been adopted by most health agencies to deal ... unnecessary, and may heighten panic and fear among the ... published in The Lancet , and written by ... in Spain, and colleagues. , Ebola virus is ... faeces and other secretions, both direct and indirect, from ...
(Date:8/28/2014)... become increasingly about datahow to gather it, organize ... databases to analyze and share data lies at ... collection, classification, storage, and analysis of biochemical and ... and methods used in bioinformatics have been instrumental ... genetics and genomics. But, in the plant sciences, ...
(Date:8/28/2014)... Worth, FL (PRWEB) August 28, 2014 Following ... on July 21, the FDA issued a warning ... the word about this harmful substance that is readily available ... , In May, high school senior Logan Stiner died from ... investigation of the substance, leading the FDA to issue a ...
(Date:8/28/2014)... researchers place glue directly on the nerve stumps, but ... and allows glue to easily invade the nerve ends. ... to insert the nerve ends into the conduit because ... Xiangdang Liang and co-workers from the General Hospital of ... technique and defined the best parameters for its use ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance Expands Staff to Meet Growing Demand for In-Home Care Services in Scottsdale 2Health News:Home Care Assistance Expands Staff to Meet Growing Demand for In-Home Care Services in Scottsdale 3Health News:The Lancet: Respiratory infection controls being used for ebola patients are unnecessary and may contribute to public panic 2Health News:Together, humans and computers can figure out the plant world 2Health News:Together, humans and computers can figure out the plant world 3Health News:FDA Issues Safety Advisory for Caffeine Powders 2
... Presents Study at International Society of Cellular Therapy ... Cells for Possible Utilization in TransplantationOLDSMAR, Fla., May ... announced results of a new study showing that ... cells from umbilical cord blood expands the number ...
... N.Y., May 5 Nutrition 21, Inc. (Nasdaq: ... help consumers manage blood sugar levels, improve cardiovascular health, enhance ... - prior to the opening of the market - on ... year 2009, ended March 31, 2009. The Company has scheduled ...
... 5 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex" or the ... independent American,provider of Western healthcare products and services ... the Company is scheduled to participate in the,Oppenheimer ... 19-21, 2009, at,300 Madison Avenue in New York ...
... Assists Physicians In Identifying Recurrence Risk and the Need ... Clarient, Inc. (Nasdaq: CLRT ... resource for pathologists, oncologists and the pharmaceutical industry, today ... test that helps physicians identify the probability of a ...
... It,s official...Curamin is the natural products industry,s Best ... number-one pain-relieving product, is slated to receive a ... magazine in its upcoming June issue. The ... based on a nationwide survey of health food ...
... medical supplies on a regular basis can save even more with ... many struggle with rising medical costs, the MSD Club membership will ... incontinence and other disposable medical supplies. , ... (PRWEB) ...
Cached Medicine News:Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 2Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 4Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 5Health News:Nutrition 21 to Report Third Quarter Fiscal Year 2009 Financial Results on Tuesday, May 12, 2009 2Health News:Chindex International, Inc. Announces May Conference Participation 2Health News:Clarient Launches New Breast Cancer Test 2Health News:Clarient Launches New Breast Cancer Test 3Health News:Clarient Launches New Breast Cancer Test 4Health News:Clarient Launches New Breast Cancer Test 5Health News:Clarient Launches New Breast Cancer Test 6Health News:Curamin Voted Best New Natural Remedy in the Country 2Health News:TheMedicalSupplyDepot.com Announces New Discount Medical Supplies MSD Club 2
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), an ... FDA clearance for and commercializing its CE Marked ... in identifying children, adolescent, and young adult patients in ... appendicitis, today announced it will present at three upcoming ... Annual Global Investment Conference being held in ...
(Date:8/28/2014)... 2014 Telik, Inc. (OTCQB: TELK), a ... with MabVax Therapeutics, Inc. on July 8, 2014, ... to the development of its lead antibody program ... the Company,s internally developed antibody discovery platform.  These ... antibody based therapeutic and diagnostic products based on ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
... traits contribute to risk, of skin cancer; findings will ... May 18 In two papers published,today, deCODE scientists ... the company,s recent findings in the genetics of pigmentation,traits ... of these,common variants also confer risk of two types ...
... Annual Meeting Will Further Demonstrate, the Strength ... CAMBRIDGE, Mass., May 16 Millennium Pharmaceuticals,The Takeda Oncology ... are scheduled to be featured at the 2008 American ... May 30 -,June 3, 2008. The data will highlight ...
Cached Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: